Compounds > acetylcysteine

acetylcysteine and bezafibrate

acetylcysteine has been researched along with bezafibrate in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's1 (10.00)29.6817
2010's8 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Bottoni, P; Ficarra, S; Giardina, B; Nocca, G; Puggioni, P; Remiddi, F; Rumi, C; Scatena, R; Sole, PD1
Abadie, C; Alvergnas, M; Blanchard, N; Gallemann, D; Heyd, B; Mantion, G; Martin, H; Richert, L1
Alvergnas, M; Ducoroy, P; Heyd, B; Lucchi, G; Martin, H; Richert, L; Rouleau, A1
Dou, X; Gu, D; Li, S; Shen, C; Song, Z; Wang, Z; Yao, T1
Ayalon, O; Saada, A; Soiferman, D; Weissman, S1
Beller, M; Giese, AK; Gläser, A; Lukas, J; Pockrandt, AM; Pohlers, S; Rolfs, A; Runge, F; Seemann, S; Sharif, M; Zheng, C1

Other Studies

10 other study(ies) available for acetylcysteine and bezafibrate

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Bezafibrate as differentiating factor of human myeloid leukemia cells.
    Cell death and differentiation, 1999, Volume: 6, Issue:8

    Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Bezafibrate; Biomarkers; Cell Cycle; Cell Differentiation; Clofibric Acid; Gemfibrozil; Growth Inhibitors; HL-60 Cells; Humans; Integrin alphaXbeta2; K562 Cells; Leukemia, Myeloid; Lipopolysaccharide Receptors; U937 Cells

1999
Regulation of CYP4A expression by bezafibrate in primary culture of rat and human hepatocytes: interspecies difference and influence of N-acetylcysteine.
    Toxicology in vitro : an international journal published in association with BIBRA, 2009, Volume: 23, Issue:7

    Topics: Acetylcysteine; Adult; Aged; Animals; Bezafibrate; Cells, Cultured; Clofibric Acid; Cytochrome P-450 CYP4A; Female; Gene Expression Regulation; Hepatocytes; Humans; Hypolipidemic Agents; Male; Middle Aged; Rats; Rats, Wistar; RNA, Messenger; Species Specificity

2009
Proteomic mapping of bezafibrate-treated human hepatocytes in primary culture using two-dimensional liquid chromatography.
    Toxicology letters, 2011, Mar-05, Volume: 201, Issue:2

    Topics: Acetylcysteine; Bezafibrate; Cells, Cultured; Chromatography, Liquid; Hepatocytes; Humans; Oxidation-Reduction; Proteomics

2011
Inhibition of NF-κB activation by 4-hydroxynonenal contributes to liver injury in a mouse model of alcoholic liver disease.
    The American journal of pathology, 2012, Volume: 181, Issue:5

    Topics: Acetylcysteine; Aldehydes; Animals; Bezafibrate; Caspases; Cell Death; Cytoprotection; Disease Models, Animal; Enzyme Activation; Ethanol; Hep G2 Cells; Hepatocytes; Humans; I-kappa B Proteins; JNK Mitogen-Activated Protein Kinases; Liver; Liver Diseases, Alcoholic; Male; Mice; Mice, Inbred C57BL; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Time Factors; Transcriptional Activation; Tumor Necrosis Factor-alpha

2012
The effect of small molecules on nuclear-encoded translation diseases.
    Biochimie, 2014, Volume: 100

    Topics: Acetylcysteine; Aminoimidazole Carboxamide; Bezafibrate; Cytochrome-c Oxidase Deficiency; DNA, Mitochondrial; Electron Transport; Electron Transport Complex IV; Fibroblasts; Gene Expression Regulation; Humans; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Myopathies; Mitochondrial Proteins; Mutation; Oxidative Phosphorylation; Peptide Elongation Factor G; Primary Cell Culture; Protein Biosynthesis; Reactive Oxygen Species; Ribonucleotides; Ribosomal Proteins; Small Molecule Libraries; tRNA Methyltransferases

2014
Enzyme enhancers for the treatment of Fabry and Pompe disease.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:3

    Topics: 1-Deoxynojirimycin; Acetylcysteine; alpha-Galactosidase; alpha-Glucosidases; Ambroxol; Bezafibrate; Enzyme Activators; Fabry Disease; Gene Expression; Glycogen Storage Disease Type II; HEK293 Cells; Humans; Leupeptins; Lysosomes; Pioglitazone; Plasmids; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Recombinant Proteins; Thiazolidinediones; Transfection

2015